These cells may actually represent the CD117+ ILCP identified later by Di Santo group (58), suggesting that an expansion of the ILC precursors can eventually be protective from GvHD, thanks to the ability of these cells to migrate to the damaged mucosa in response to inflammatory cytokines and give rise to the specialized ILC subsets. Here, CCL27 is linked to graft versus host disease.